Our paper provides some evidence that AGP can be used as a potential prognostication biomarker for PAD, adding to our repository of potential biomarkers to improve prognosis of this condition via a multifaceted approach (7–10). This evidence concerns the gene ATP5MK and peripheral arterial disease.